Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Melanoma
Douglas B. Johnson, Igor Puzanov, Mark C. Kelley
Immunotherapy (2015) Vol. 7, Iss. 6, pp. 611-619
Open Access | Times Cited: 171

Showing 26-50 of 171 citing articles:

Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?
Faith Howard, Amy Kwan, Natalie Winder, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 39
In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
Lin Zhong-da, Fanqiang Meng, Yumeng Ma, et al.
Bioactive Materials (2023) Vol. 32, pp. 12-27
Open Access | Times Cited: 23
A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy
Mengyu Chang, Man Wang, Bin Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8143-8156
Closed Access | Times Cited: 10
Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy
Ali Zarezadeh Mehrabadi, Mahdi Tat, Akbar Ghorbani Alvanegh, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy
Yingxuan Zhang, Zheyan Fang, Ruizhen Li, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1314-1314
Open Access | Times Cited: 74
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Manisha Singh, Christina Vianden, Mark J. Cantwell, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
Hardev Pandha, Guy R. Simpson, Kate Relph, et al.
Oncolytic Virotherapy (2016), pp. 1-1
Open Access | Times Cited: 67
Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model
Avner Friedman, Xiulan Lai
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0192449-e0192449
Open Access | Times Cited: 63
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Chun‐Yu Chen, Brian Hutzen, Mary Frances Wedekind, et al.
Oncolytic Virotherapy (2018) Vol. Volume 7, pp. 65-77
Open Access | Times Cited: 62
Advances in engineering local drug delivery systems for cancer immunotherapy
Peter Abdou, Zejun Wang, Qian Chen, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2020) Vol. 12, Iss. 5
Open Access | Times Cited: 57
Development of oncolytic virotherapy: from genetic modification to combination therapy
Qiaoshuai Lan, Shuai Xia, Qian Wang, et al.
Frontiers of Medicine (2020) Vol. 14, Iss. 2, pp. 160-184
Open Access | Times Cited: 56
Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
Chang-Gon Kim, Yun Beom Sang, Ji Hyun Lee, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8035-8035
Open Access | Times Cited: 52
Recent advances in immunotherapy for hepatocellular carcinoma
Abid Khan, Zhikun Liu, Xiao Xu
Hepatobiliary & pancreatic diseases international (2021) Vol. 20, Iss. 6, pp. 511-520
Closed Access | Times Cited: 47
The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles
Guijin Tang, Dawei Wang, Xiangqian Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3681-3681
Open Access | Times Cited: 21
Development and application of oncolytic viruses as the nemesis of tumor cells
Xiao Zhu, Chenyang Fan, Zhuolong Xiong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 20
Recent advances in oncolytic virus-based cancer therapy
Luo‐Qin Fu, Shibing Wang, Mao-Hua Cai, et al.
Virus Research (2019) Vol. 270, pp. 197675-197675
Closed Access | Times Cited: 51
Nanosystems for Improved Targeted Therapies in Melanoma
Cristina Beiu, Călin Giurcăneanu, Alexandru Mihai Grumezescu, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 318-318
Open Access | Times Cited: 48
Adverse Events of Oncologic Immunotherapy and Their Management
Fedricker Diane Barber
Asia-Pacific Journal of Oncology Nursing (2019) Vol. 6, Iss. 3, pp. 212-226
Open Access | Times Cited: 46
STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
Xiaoyan Shao, Xueke Wang, Xianling Guo, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 43
A new oncolyticVacciniavirusaugments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
Jahangir Ahmed, Louisa S. Chard, Ming Yuan, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000415-e000415
Open Access | Times Cited: 43
Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
Lydia G. White, Hannah E. Goy, Alinor J. Rose, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 978-978
Open Access | Times Cited: 25
Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus
Faith Howard, Haider Al‐Janabi, Priya Patel, et al.
Small (2022) Vol. 18, Iss. 13
Open Access | Times Cited: 24
Emerging treatment strategies for metastatic triple-negative breast cancer
Laura A. Huppert, Özge Gümüşay, Hope S. Rugo
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 24
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 14
The Diagnosis and Management of Cutaneous Metastases from Melanoma
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14535-14535
Open Access | Times Cited: 14

Scroll to top